Bone morphogenetic protein signaling has long been established as a crucial pathway during embryonic development. In recent years, our knowledge of the function of bone morphogenetic protein signaling has expanded dramatically beyond solely its important role in development. Today, the pathway is known to have important homeostatic functions across multiple different tissues in the adult. Even more importantly, bone morphogenetic protein signaling is now known to function as a driver of diseases in the adult spanning different organ systems. In this review, we will explore the functions of bone morphogenetic protein signaling in diseases of inflammation. Through this exploration, we will highlight the value and challenges in targeting bone morphogenetic protein signaling for therapeutic interventions.
Impact statement
By compiling findings from recent studies, this review will garner novel insight on the dynamic and complex role of BMP signaling in diseases of inflammation, highlighting the specific roles played by both individual ligands and endogenous antagonists. Ultimately, this summary will help inform the high therapeutic value of targeting this pathway for modulating diseases of inflammation.
UristMR.Bone formation by autoinduction. Science1965;
150:893–9
2.
UristMRMikulskiALietzeA.Solubilized and insolubilized bone morphogenetic protein. Proc Natl Acad Sci U S A1979;
76:1828–32
3.
WozneyJMRosenVCelesteAJMitsockLMWhittersMJKrizRWHewickRMWangEA.Novel regulators of bone formation: molecular clones and activities. Science1988;
242:1528–34
4.
SalazarVSGamerLWRosenV.BMP signaling in skeletal development, disease and repair. Nat Rev Endocrinol2016;
12:203–21
5.
KesslerETakaharaKBiniaminovLBruselM.Bone morphogenetic protein-1: the type I procollagen c-proteinase. Science1996;
271:360–2
6.
HarrisonCAAl-MusawiSLWaltonKL.Prodomains regulate the synthesis, extracellular localisation and activity of TGF-β superfamily ligands. Growth Factors2011;
29:174–86
7.
RahmanMSAkhtarNJamilHMBanikRSAsaduzzamanSM.TGF-β/BMP signaling and other molecular events: regulation of osteoblastogenesis and bone formation. Bone Res2015;
3:15005
8.
YamaguchiKShirakabeKShibuyaHIrieKOishiIUenoNTaniguchiTNishidaEMatsumotoK.Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science1996;
270:2008–11
9.
DerynckRZhangYE.Smad-dependent and Smad-independent pathways in TGF-β family signaling. Nature2003;
425:577–84
10.
ZhangYE.Non-Smad pathways in TGF-β signaling. Cell Res2009;
19:128–39
11.
TraegerLGallitzISekhriRBäumerNKuhlmannTKemmingCHoltkampMMüllerJCKarstUCanonne-HergauxFMuckenthalerMUBlochDBOlschewskiABartnikasTBSteinbickerAU.ALK3 undergoes ligand-independent homodimerization and BMP-induced heterodimerization with ALK2. Free Radic Biol Med2018;
129:127–37
12.
LittleSCMullinsMC.Bone morphogenetic protein heterodimers assemble heteromeric type I receptor complexes to pattern the dorsoventral axis. Nat Cell Biol2009;
11:637–43
13.
NolanKKattamuriCLuedekeDMDengXJagpalAZhangFLinhardtRJKennyAPZornAMThompsonTB.Structure of protein related to Dan and Cerberus: insights into the mechanism of bone morphogenetic protein antagonism. Structure2013;
21:1417–29
14.
GroppeJGreenwaldJWiaterERodriguez-LeonJEconomidesANKwiatkowskiWAffolterMValeWWIzpisua BelmonteJCChoeS.Structural basis of BMP signaling inhibition by the cystine knot protein Noggin. Nature2002;
420:636–42
15.
KattamuriCLuedekeDMNolanKRankinSAGreisKDZornAMThompsonTB.Members of the DAN family are BMP antagonists that form highly stable noncovalent dimers. J Mol Biol2012;
424:313–27
16.
NolanKKattamuriCRankinSAReadRJZornAMThompsonTB.Structure of Gremlin-2 in fact complex with GDF5 gives insight into DAN-family-mediated BMP antagonism. Cell Rep2016;
16:2077–86
17.
SudoSAvsian-KretchmerOWangLSHsuehAJW.Protein related to DAN and cerberus is a bone morphogenetic protein antagonist that participates in ovarian paracrine regulation. J Biol Chem2004;
279:23134–41
18.
ItohSten DijkeP.Negative regulation of TGF-β receptor/Smad signal transduction. Curr Opin Cell Biol2007;
19:176–84
19.
KnockaertMSapkotaGAlarcónCMassaguéJBrivanlouAH.Unique players in the BMP pathway: small C-terminal domain phosphatases dephosphorylate Smad1 to attenuate BMP signaling. Proc Natl Acad Sci U S A2006;
103:11940–5
20.
HeldinCHMoustakasA.Role of Smads in TGFβ signaling. Cell Tissue Res2012;
347:21–36
21.
ZhangHBradleyA.Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development1996;
122:2977–86
22.
WinnierGBlessingMLaboskyPAHoganBLM.Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. GenesDevelop1995;
9:2105–16
23.
ChenH, Shi S, Acosta L, Li W, Lu J, Bao S, Chen Z, Yang Z, Schneider MD, Chien KR,Conway SJ, Yoder MC, Haneline LS, Franco D, Shou W.
BMP10 is essential for maintaining cardiac growth during murine cardiogenesis. Development2004;
131:2219–31
24.
DudleyATLyonsKMRobertsonEJ.A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Develop1995;
9:2795–807
25.
McpherronACLawlerAMLeeS.Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11. Nat Genet1999;
22:260–4
26.
KomatsuYScottGNagyAKaartinenVMishinaY.BMP type I receptor Alk2 is essential for proper patterning at late gastrulation during mouse embryogenesis. Dev Dyn2007;
236:512–7
27.
BeppuHet al.
BMP type II receptor is required for gastrulation and early development of mouse embryos. Dev Biol2000;
221:249–58
28.
MishinaYSuzukiAUenoNBehringerRR.Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev1995;
9:3027–37
29.
SirardCde la PompaJLEliaAItieAMirtsosCCheungAHahnSWakehamASchwartzLKernSERossantJMakTW.The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev1998;
12:107–19
30.
ChangHHuylebroeckDVerschuerenKGuoQMatzukMMZwijsenA.Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects. Development1999;
126:1631–42
31.
LechleiderRJRyanJLGarrettLEngCDengCWynshaw-BorisARobertsAB.Targeted mutagenesis of Smad1 reveals an essential role in chorioallantoic fusion. Dev Biol2001;
240:157–67
32.
ChenQChenHZhengDKuangCFangHZouBZhuWBuGJinTWangZZhangXChenJFieldLJRubartMShouWChenY.Smad7 is required for the development and function of the heart. J Biol Chem2009;
284:292–300
33.
SchmidtJESuzukiAUenoNKimelmanD.Localized BMP-4 mediates dorsal/ventral patterning in the early xenopus embryo. Dev Biol1995;
169:37–50
34.
GoldmanDCBaileyASPfaffleDLAl MasriAChristianJLFlemingWH.BMP4 regulates the hematopoietic stem cell niche. Blood2009;
114:4393–401
35.
MaLLuMFSchwartzRJMartinJF.Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. Development2005;
132:5601–11
36.
Rivera-FelicianoJTabinCJ.Bmp2 instructs cardiac progenitors to form the heart-valve-inducing field. Dev Biol2006;
295:580–8
37.
WangJGreeneSBBonilla-ClaudioMTaoYZhangJBaiYHuangZBlackBLWangFMartinJF.Bmp signaling regulates myocardial differentiation from cardiac progenitors through a microRNA-mediated mechanism. Dev Cell2010;
19:903–12
38.
de PaterECiampricottiMPrillerFVeerkampJStrateISmithKLagendijkAKSchillingTFHerzogWAbdelilah-SeyfriedSHammerschmidtMBakkersJ.BMP signaling exerts opposite effects on cardiac differentiation. Circ Res2012;
110:578–87
39.
KishigamiSYoshikawaSCastranioTOkazakiKFurutaYMishinaY.BMP signaling through ACVRI is required for left-right patterning in the early mouse embryo. Dev Biol2004;
276:185–93
40.
ChocronSVerhoevenMCRentzschFHammerschmidtMBakkersJ.Zebrafish Bmp4 regulates left-right asymmetry at two distinct developmental time points. Dev Biol2007;
305:577–88
41.
MonteiroRvan DintherMBakkersJWilkinsonRPatientRten DijkePMummeryC.Two novel type II receptors mediate BMP signalling and are required to establish left-right asymmetry in zebrafish. Dev Biol2008;
315:55–71
42.
FurtadoMBSollowayMJJonesVJCostaMWBibenCWolsteinOPreisJISparrowDBSagaYDunwoodieSLRobertsonEJTamPPHarveyRP.BMP/SMAD1 signaling sets a threshold for the left/right pathway in lateral plate mesoderm and limits availability of SMAD4. Genes Dev2008;
22:3037–49
43.
LeeKJMendelsohnMJessellTM.Neuronal patterning by BMPs: a requirement for GDF7 in the generation of a discrete class of commissural interneurons in the mouse spinal cord. Genes Dev1998;
12:3394–407
44.
WuH-HIvkovicSMurrayRCJaramilloS.Autoregulation of neurogenesis by GDF11. Neuron2003;
37:197–207
45.
WangRNGreenJWangZDengYQiaoMPeabodyMZhangQYeJYanZDenduluriSIdowuOLiMShenCHuAHaydonRCKangRMokJLeeMJLuuHLShiLL.Bone morphogenetic protein (BMP) signaling in development and human diseases. Genes Dis2014;
1:87–105
46.
SasaiYLuBSteinbeisserHDe RobertisEM.Regulation of neural induction by the Chd and Bmp-4 antagonistic patterning signals in Xenopus. Nature1995;
376:333–6
47.
BachillerDKlingensmithJKempCBeloJAAndersonRMMaySRMcMahonJAMcMahonAPHarlandRMRossantJDe RobertisEM.The organizer factors Chordin and Noggin are required for mouse forebrain development. Nature2000;
403:658–61
48.
WijgerdeMKarpSMcMahonJMcMahonAP.Noggin antagonism of BMP4 signaling controls development of the axial skeleton in the mouse. Dev Biol2005;
286:149–57
49.
MüllerIIMelvilleDBTanwarVRybskiWMMukherjeeAShoemakerMBWangWDSchoenhardJARodenDMDarbarDKnapikEWHatzopoulosAK.Functional modeling in zebrafish demonstrates that the atrial-fibrillation-associated gene GREM2 regulates cardiac laterality, cardiomyocyte differentiation and atrial rhythm. Dis Model Mech2013;
6:332–41
ParrowNLFlemingRE.Bone morphogenetic proteins as regulators of iron metabolism. Annu Rev Nutr2014;
34:77–94
52.
OrriolsMGomez-PuertoMCTen DijkeP.BMP type II receptor as a therapeutic target in pulmonary arterial hypertension. Cell Mol Life Sci2017;
74:1–17
53.
LoweryJWde CaesteckerMP.BMP signaling in vascular development and disease. Cytokine Growth Factor Rev2010;
21:287–98
54.
BandyopadhyayAYadavPSPrasharP.BMP signaling in development and diseases: a pharmacological perspective. Biochem Pharmacol2013;
85:857–64
55.
RossR.Atherosclerosis – an inflammatory disease. N Engl J Med1999;
340:115–26
56.
LibbyPRidkerPMMaseriA.Inflammation and atherosclerosis. Circulation2002;
105:1135–43
57.
LibbyP.Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol2012;
32:2045–51
58.
CsiszarASmithKEKollerAKaleyGEdwardsJGUngvariZ.Regulation of bone morphogenetic protein-2 expression in endothelial cells: role of nuclear factor-kappaB activation by tumor necrosis factor-alpha, H2O2, and high intravascular pressure. Circulation2005;
111:2364–72
59.
SorescuGPSykesMWeissDPlattMOSahaAHwangJBoydNBooYCVegaJDTaylorWRJoH.Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress stimulates an inflammatory response. J Biol Chem2003;
278:31128–35
60.
SucoskyPBalachandranKElhammaliAJoHYoganathanAP.Altered shear stress stimulates upregulation of endothelial VCAM-1 and ICAM-1 in a BMP-4- and TGF-β1-dependent pathway. Arterioscler Thromb Vasc Biol2009;
29:254–60
61.
HelbingTRothweilerRKettererEGoetzLHeinkeJGrundmannSDuerschmiedDPattersonCBodeCMoserM.BMP activity controlled by BMPER regulates the proinflammatory phenotype of endothelium. Blood2011;
118:5040–9
62.
PardaliEMakowskiL-MLeffersMBorgscheiperAWaltenbergerJ.BMP-2 induces human mononuclear cell chemotaxis and adhesion and modulates monocyte-to-macrophage differentiation. J Cell Mol Med2018;
22:5429–38
ChangKWeissDSuoJVegaJDGiddensDTaylorWRJoH.Bone morphogenic protein antagonists are coexpressed with bone morphogenic protein 4 in endothelial cells exposed to unstable flow in vitro in mouse aortas and in human coronary arteries: role of bone morphogenic protein antagonists in inflammation and atherosclerosis. Circulation2007;
116:1258–66
65.
YaoYBennettBJWangXRosenfeldMEGiachelliCLusisAJBoströmKI.Inhibition of bone morphogenetic proteins protects against atherosclerosis and vascular calcification. Circ Res2010;
107:485–94
66.
PiXLockyerPDyerLASchislerJCRussellBCareySSweetDTChenZTzimaEWillisMSHomeisterJWMoserMPattersonC.Bmper inhibits endothelial expression of inflammatory adhesion molecules and protects against atherosclerosis. Arterioscler Thromb Vasc Biol2012;
32:2214–22
67.
KogaMEngberdingNDikalovaAEChangKHSeidel-RogolBLongJSLassègueBJoHGriendlingKK.The bone morphogenic protein inhibitor, noggin, reduces glycemia and vascular inflammation in db/db mice. AJP Heart Circ Physiol2013;
305:H747–55
68.
HruskaKAMathewSSaabG.Bone morphogenetic proteins in vascular calcification. Circ Res2005;
97:105–14
69.
HedinURoyJTranPKLundmarkKRahmanA.Control of smooth muscle cell proliferation – the role of the basement membrane. Thromb Haemost1999;
82(Suppl 1):23–6
70.
WorthNFRolfeBESongJCampbellGR.Vascular smooth muscle cell phenotypic modulation in culture is associated with reorganisation of contractile and cytoskeletal proteins. Cell Motil Cytoskeleton2001;
49:130–45
71.
BoströmKWatsonKEHornSWorthamCHermanIMDemerLL.Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest1993;
91:1800–9
72.
NakaokaTGondaKOgitaTOtawara-HamamotoYOkabeFKiraYHariiKMiyazonoKTakuwaYFujitaT.Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2. J Clin Invest1997;
100:2824–32
73.
WongGATangVEl-SabeawyFWeissRH.BMP-2 inhibits proliferation of human aortic smooth muscle cells via p21(Cip1/Waf1). Am J Physiol Metab2003;
284:E972–9
74.
KingKEIyemereVPWeissbergPLShanahanCM.Krüppel-like factor 4 (KLF4/GKLF) is a target of bone morphogenetic proteins and transforming growth factor β1 in the regulation of vascular smooth muscle cell phenotype. J Biol Chem2003;
278:11661–9
ShaoJSAlyZALaiCFChengSLCaiJHuangEBehrmannATowlerDA.Vascular Bmp-Msx2-Wnt signaling and oxidative stress in arterial calcification. Ann N Y Acad Sci2007;
1117:40–50
77.
LiXYangHYGiachelliCM.BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. Atherosclerosis2008;
199:271–7
78.
AndradeMCCarmoLSFarias-SilvaELibermanM.Msx2 is required for vascular smooth muscle cells osteoblastic differentiation but not calcification in insulin-resistant ob/ob mice. Atherosclerosis2017;
265:14–21
79.
TakaradaTNakazatoRTsuchikaneAFujikawaKIezakiTYonedaYHinoiE.Genetic analysis of Runx2 function during intramembranous ossification. Development2016;
143:211–8
80.
KomoriT.Regulation of osteoblast differentiation by transcription factors. J Cell Biochem2006;
99:1233–9
81.
TanakaTSatoHDoiHYoshidaCAShimizuTMatsuiHYamazakiMAkiyamaHKawai-KowaseKIsoTKomoriTAraiMKurabayashiM.Runx2 represses myocardin-mediated differentiation and facilitates osteogenic conversion of vascular smooth muscle cells. Mol Cell Biol2008;
28:1147–2
82.
DerwallMMalhotraRLaiCSBeppuYAikawaESeehraJSZapolWMBlochKDYuPB.Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis. Arterioscler Thromb Vasc Biol2012;
32:613–22
83.
YungLMSánchez-DuffhuesGTen DijkePYuPB.Bone morphogenetic protein 6 and oxidized low-density lipoprotein synergistically recruit osteogenic differentiation in endothelial cells. Cardiovasc Res2015;
108:278–87
84.
Parra-IzquierdoICastaños-MollorILópezJGómezCSan RománJASánchez CrespoMGarcía-RodríguezC.Calcification induced by type I interferon in human aortic valve interstitial cells is larger in males and blunted by a janus kinase inhibitor. Arterioscler Thromb Vasc Biol2018;
38:2148–59
85.
LeeSBKalluriR.Mechanistic connection between inflammation and fibrosis. Kidney Int2010;
78:S22–6
86.
MackM.Inflammation and fibrosis. Matrix Biol2018;
68–69:106–21
ZeisbergMShahAAKalluriR.Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J Biol Chem2005;
280:8094–100
92.
WangSdeCMKoppJMituGLapageJHirschbergR.Renal bone morphogenetic protein-7 protects against diabetic nephropathy. J Am Soc Nephrol2006;
17:2504–12
93.
SugimotoHGrahovacGZeisbergMKalluriR.Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors. Diabetes2007;
56:1825–33
KinoshitaKIimuroYOtogawaKSaikaSInagakiYNakajimaYKawadaNFujimotoJFriedmanSLIkedaK.Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats. Gut2007;
56:706–14
96.
PegorierSCampbellGAKayABLloydCM.Bone morphogenetic protein (BMP)-4 and BMP-7 regulate differentially transforming growth factor (TGF)-β1 in normal human lung fibroblasts (NHLF). Respir Res2010;
11:85
97.
LiangDWangYZhuZYangGAnGLiXNiuPChenLTianL.BMP-7 attenuated silica-induced pulmonary fibrosis through modulation of the balance between TGF-β/Smad and BMP-7/Smad signaling pathway. Chem Biol Interact2016;
243:72–81
98.
LiXAnGWangYLiangDZhuZLianXNiuPGuoCTianL.Anti-fibrotic effects of bone morphogenetic protein-7-modified bone marrow mesenchymal stem cells on silica-induced pulmonary fibrosis. Exp Mol Pathol2017;
102:70–7
99.
ChenPSimonsM.When endothelial cells go rogue. Embo Mol Med2015;
8:1–2
100.
PérezLMuñoz-DurangoNRiedelCAEcheverríaCKalergisAMCabello-VerrugioCSimonF.Endothelial-to-mesenchymal transition: cytokine-mediated pathways that determine endothelial fibrosis under inflammatory conditions. Cytokine Growth Factor Rev2017;
33:41–54
101.
ZeisbergEMTarnavskiOZeisbergMDorfmanALMcMullenJRGustafssonEChandrakerAYuanXPuWTRobertsABNeilsonEGSayeghMHIzumoSKalluriR.Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med2007;
13:952–61
102.
Aisagbonhi O, Meena R, Ryzhov S, Atria N, Feoktistov I, Hatzopoulos AK. Experimental myocardialinfarction triggers canonical Wnt signaling and endothelial-to-mesenchymal transition. Dis Model Mech 2011;4:469–83
103.
DejanaEHirschiKKSimonsM.The molecular basis of endothelial cell plasticity. Nat Commun2017;
8:14361
104.
LiYLuiKOZhouB.Reassessing endothelial-to-mesenchymal transition in cardiovascular diseases. Nat Rev Cardiol2018;
15:445–56
105.
YaoYJumabayMLyARadparvarMCubberlyMRBoströmKI.A role for the endothelium in vascular calcification. Circ Res2013;
113:495–504
106.
McCulleyDJKangJOMartinJFBlackBL.BMP4 is required in the anterior heart field and its derivatives for endocardial cushion remodeling, outflow tract septation, and semilunar valve development. Dev Dyn2008;
237:3200–9
107.
MediciDShoreEMLounevVYKaplanFSKalluriROlsenBR.Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med2010;
16:1400–6
108.
HaoJHoJNLewisJAKarimKADanielsRNGentryPRHopkinsCRLindsleyCWHongCC.In vivo structure – activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors. ACS Chem Biol2010;
5:245–53
109.
OwensPPickupMWNovitskiySVGiltnaneJMGorskaAEHopkinsCRHongCCMosesHL.Inhibition of BMP signaling suppresses metastasis in mammary cancer. Oncogene2015;
34:2437–49
110.
MaddalunoLRudiniNCuttanoRBraviLGiampietroCCoradaMFerrariniLOrsenigoFPapaEBouldayGTournier-LasserveEChaponFRichichiCRettaSFLampugnaniMGDejanaE.EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature2013;
498:492–6
111.
RiberaJPautaMMelgar-LesmesPCórdobaBBoschACalvoMRodrigo-TorresDSancho-BruPMiraAJiménezWMorales-RuizM.A small population of liver endothelial cells undergoes endothelial-to-mesenchymal transition in response to chronic liver injury. Am J Physiol Liver Physiol2017;
313:G492–504
112.
DuttaPCourtiesGWeiYLeuschnerFGorbatovRRobbinsCSIwamotoYThompsonBCarlsonALHeidtTMajmudarMDLasitschkaFEtzrodtMWatermanPWaringMTChicoineATvan der LaanAMNiessenHWPiekJJRubinBBButanyJStoneJRKatusHAMurphySAMorrowDASabatineMSVinegoniCMoskowitzMAPittetMJLibbyPLinCPSwirskiFKWeisslederRNahrendorfM.Myocardial infarction accelerates atherosclerosis. Nature2012;
487:325–9
113.
ZouggariYAit-OufellaHBonninPSimonTSageAPGuérinCVilarJCaligiuriGTsiantoulasDLauransLDumeauEKottiSBrunevalPCharoIFBinderCJDanchinNTedguiATedderTFSilvestreJSMallatZ.B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat Med2013;
19:1273–80
114.
FrantzSNahrendorfM.Cardiac macrophages and their role in ischaemic heart disease. Cardiovasc Res2014;
102:240–8
115.
DuttaPSagerHBStengelKRNaxerovaKCourtiesGSaezBSilbersteinLHeidtTSebasMSunYWojtkiewiczGFeruglioPFKingKBakerJNvan der LaanAMBorodovskyAFitzgeraldKHulsmansMHoyerFIwamotoYVinegoniCBrownDDi CarliMLibbyPHiebertSWScaddenDTSwirskiFKWeisslederRNahrendorfM.Myocardial infarction activates CCR2+ hematopoietic stem and progenitor cells. Cell Stem Cell2015;
16:477–87
116.
NahrendorfMSwirskiFK.Innate immune cells in ischaemic heart disease: does myocardial infarction beget myocardial infarction?Eur Heart J2016;
37:868–72
117.
ChangSALeeEJKangHJZhangSYKimJHLiLYounSWLeeCSKimKHWonJYSohnJWParkKWChoHJYangSEOhWIYangYSHoWKParkYBKimHS.Impact of myocardial infarct proteins and oscillating pressure on the differentiation of mesenchymal stem cells: effect of acute myocardial infarction on stem cell differentiation. Stem Cells2008;
26:1901–12
118.
VarasAValenciaJLavocatFMartínezVGThiamNNHidalgoLFernández-SevillaLMSacedónRVicenteAMiossecP.Blockade of bone morphogenetic protein signaling potentiates the pro-inflammatory phenotype induced by interleukin-17 and tumor necrosis factor-α combination in rheumatoid synoviocytes. Arthritis Res Ther2015;
17:192
119.
LoriesRJUDereseICeuppensJLLuytenFP.Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis. Arthritis Rheum2003;
48:2807–18
120.
BramlageCPHäuplTKapsCUngethümUKrennVPrussAMüllerGAStrutzFBurmesterGR.Decrease in expression of bone morphogenetic proteins 4 and 5 in synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Arthritis Res Ther2006;
8:R58
121.
HotAZrioualSTohMLLeniefVMiossecP.IL-17A- versus IL-17F-induced intracellular signal transduction pathways and modulation by IL-17RA and IL-17RC RNA interference in rheumatoid synoviocytes. Ann Rheum Dis2011;
70:341–8
122.
HotAZrioualSLeniefVMiossecP.IL-17 and tumour necrosis factor α combination induces a HIF-1α-dependent invasive phenotype in synoviocytes. Ann Rheum Dis2012;
71:1393–401
123.
LoriesRJUDereseILuytenFP.Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest2005;
115:1571–9
124.
FillebeenCWilkinsonNCharleboisEKatsarouAWagnerJPantopoulosK.Hepcidin-mediated hypoferremic response to acute inflammation requires a threshold of Bmp6/Hjv/Smad signaling. Blood2018;
132:1829–41
125.
NemethETuttleMSPowelsonJVaughnMBDonovanAWardDMGanzTKaplanJ.Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science2004;
306:2090–3
126.
BabittJLHuangFWWrightingDMXiaYSidisYSamadTACampagnaJAChungRTSchneyerALWoolfCJAndrewsNCLinHY.Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet2006;
38:531–9
127.
AndriopoulosBJrCorradiniEXiaYFaasseSAChenSGrgurevicLKnutsonMDPietrangeloAVukicevicSLinHYBabittJL.BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet2009;
41:482–7
128.
KautzLMeynardDMonnierADarnaudVBouvetRWangRHDengCVaulontSMosserJCoppinHRothMP.Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood2008;
112:1503–9
129.
MeynardDKautzLDarnaudVCanonne-HergauxFCoppinHRothMP.Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet2009;
41:478–81
130.
TruksaJPengHLeePBeutlerE.Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proc Natl Acad Sci U S A2006;
103:10289–93
131.
WangCYCanaliSBayerADevSAgarwalABabittJL.Iron, erythropoietin, and inflammation regulate hepcidin in BMP2 -deficient mice, but serum iron fails to induce hepcidin in BMP6 -deficient mice. Am J Hematol2018;
94:240–8
132.
MayeurCLeytonPAKolodziejSAYuBBlochKD.BMP type II receptors have redundant roles in the regulation of hepatic hepcidin gene expression and iron metabolism. Blood2014;
124:2116–23
133.
SteinbickerAUBartnikasTBLohmeyerLKLeytonPMayeurCKaoSMPappasAEPetersonRTBlochDBYuPBFlemingMDBlochKD.Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice. Blood2011;
118:4224–30
134.
WangRHLiCXuXZhengYXiaoCZerfasPCoopermanSEckhausMRouaultTMishraLDengCX.A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab2005;
2:399–409
135.
SteinbickerAUSachidanandanCVonnerAJYusufRZDengDYLaiCSRauwerdinkKMWinnJCSaezBCookCMSzekelyBARoyCNSeehraJSCunyGDScaddenDTPetersonRTBlochKDYuPB.Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation. Blood2011;
117:4915–23
136.
TheurlISchrollASonnweberTNairzMTheurlMWillenbacherWEllerKWolfDSeifertMSunCCBabittJLHongCCMenhallTGearingPLinHYWeissG.Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats. Blood2011;
118:4977–84
137.
GallitzILofrutheNTraegerLBäumerNHoerrVFaberCKuhlmannTMüller-TidowCSteinbickerAU.Deficiency of the BMP Type I receptor Alk3 partly protects mice from anemia of inflammation. BMC Physiol2018;
18:3
138.
CarvalhoDOlacireguiNGRuddleRDonovanAPalARaynaudFRichardsonPJCarcabosoAMJonesC.Preclinical efficacy of combined ACVR1 and PI3K/mTOR inhibition in diffuse intrinsic pontine glioma (DIPG). Neuro Oncol2018;
20:i54–5
